IBDEI271 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36827,0)
 ;;=C78.02^^169^1860^11
 ;;^UTILITY(U,$J,358.3,36827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36827,1,3,0)
 ;;=3^Secondary malignant neoplasm of left lung
 ;;^UTILITY(U,$J,358.3,36827,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,36827,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,36828,0)
 ;;=C78.7^^169^1860^12
 ;;^UTILITY(U,$J,358.3,36828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36828,1,3,0)
 ;;=3^Secondary malignant neoplasm of liver and intrahepatic bile duct
 ;;^UTILITY(U,$J,358.3,36828,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,36828,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,36829,0)
 ;;=C79.2^^169^1860^19
 ;;^UTILITY(U,$J,358.3,36829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36829,1,3,0)
 ;;=3^Secondary malignant neoplasm of skin
 ;;^UTILITY(U,$J,358.3,36829,1,4,0)
 ;;=4^C79.2
 ;;^UTILITY(U,$J,358.3,36829,2)
 ;;=^267333
 ;;^UTILITY(U,$J,358.3,36830,0)
 ;;=C79.31^^169^1860^4
 ;;^UTILITY(U,$J,358.3,36830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36830,1,3,0)
 ;;=3^Secondary malignant neoplasm of brain
 ;;^UTILITY(U,$J,358.3,36830,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,36830,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,36831,0)
 ;;=C79.32^^169^1860^5
 ;;^UTILITY(U,$J,358.3,36831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36831,1,3,0)
 ;;=3^Secondary malignant neoplasm of cerebral meninges
 ;;^UTILITY(U,$J,358.3,36831,1,4,0)
 ;;=4^C79.32
 ;;^UTILITY(U,$J,358.3,36831,2)
 ;;=^5001348
 ;;^UTILITY(U,$J,358.3,36832,0)
 ;;=C79.49^^169^1860^16
 ;;^UTILITY(U,$J,358.3,36832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36832,1,3,0)
 ;;=3^Secondary malignant neoplasm of oth parts of nervous system
 ;;^UTILITY(U,$J,358.3,36832,1,4,0)
 ;;=4^C79.49
 ;;^UTILITY(U,$J,358.3,36832,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,36833,0)
 ;;=C79.51^^169^1860^2
 ;;^UTILITY(U,$J,358.3,36833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36833,1,3,0)
 ;;=3^Secondary malignant neoplasm of bone
 ;;^UTILITY(U,$J,358.3,36833,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,36833,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,36834,0)
 ;;=C79.52^^169^1860^3
 ;;^UTILITY(U,$J,358.3,36834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36834,1,3,0)
 ;;=3^Secondary malignant neoplasm of bone marrow
 ;;^UTILITY(U,$J,358.3,36834,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,36834,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,36835,0)
 ;;=C79.71^^169^1860^17
 ;;^UTILITY(U,$J,358.3,36835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36835,1,3,0)
 ;;=3^Secondary malignant neoplasm of right adrenal gland
 ;;^UTILITY(U,$J,358.3,36835,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,36835,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,36836,0)
 ;;=C79.72^^169^1860^10
 ;;^UTILITY(U,$J,358.3,36836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36836,1,3,0)
 ;;=3^Secondary malignant neoplasm of left adrenal gland
 ;;^UTILITY(U,$J,358.3,36836,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,36836,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,36837,0)
 ;;=C77.5^^169^1860^8
 ;;^UTILITY(U,$J,358.3,36837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36837,1,3,0)
 ;;=3^Secondary malignant neoplasm of intrapelvic nodes
 ;;^UTILITY(U,$J,358.3,36837,1,4,0)
 ;;=4^C77.5
 ;;^UTILITY(U,$J,358.3,36837,2)
 ;;=^267319
 ;;^UTILITY(U,$J,358.3,36838,0)
 ;;=C48.2^^169^1861^24
 ;;^UTILITY(U,$J,358.3,36838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36838,1,3,0)
 ;;=3^Malignant neoplasm of peritoneum, unspecified
 ;;^UTILITY(U,$J,358.3,36838,1,4,0)
 ;;=4^C48.2
 ;;^UTILITY(U,$J,358.3,36838,2)
 ;;=^5001122
 ;;^UTILITY(U,$J,358.3,36839,0)
 ;;=C45.0^^169^1861^30
 ;;^UTILITY(U,$J,358.3,36839,1,0)
 ;;=^358.31IA^4^2
